Skip to content

Evaluation of a new device for early detection of breast cancer

Evaluation of Breastlight as a tool for early detection of breast cancer in women positive on clinical breast examination or at high risk of having breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/09/015759
Enrollment
2000
Registered
2018-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D249- Benign neoplasm of unspecified breast

Interventions

Intervention1: Breastlight: Breastlight is a low cost, feasible and point of care technology to triage CBE positive women will greatly improve the efficiency of CBE screening. Control Intervention1: N

Sponsors

NICPR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women aged 30-69 years without any prior diagnosis of breast cancer, referred to the Breast Clinics at the study centers due to breast abnormalities detected on clinical breast examination will be recruited in the study after informed consenting. 2. Women of any age requiring examination of the contralateral breast due to prior diagnosis of breast cancer will also be recruited to the study

Exclusion criteria

Exclusion criteria: 1. Women diagnosed with breast cancer 2. Women not consenting for the study

Design outcomes

Primary

MeasureTime frame
1. Sensitivity, specificity, negative and positive predictive values of Breastlight with mammography and/or cytology/core biopsy as the gold standard verification test 2. The agreement between the breastlight and ultrasound diagnosis 3. Improvement in the PPV of CBE by Breastlight triaging 4. Loss in the sensitivity of CBE by Breastlight triaging Timepoint: At confirmation by tissue diagnosis

Secondary

MeasureTime frame
Size (T status) of the breast cancer according to Breastlight resultsTimepoint: After the staging workup

Countries

India

Contacts

Public ContactRoopa Hariprasad

National Institute of Cancer Prevention and Research

roopaicmr@gmail.com9818278797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026